You searched for "blurred"
University of Gloucestershire launches first of its kind ophthalmic imaging degree
Ophthalmic science is a dynamic and constantly evolving profession, with ophthalmic imagers / technicians fundamental to the smooth and efficient running of ophthalmology departments. Traditionally, as the role has developed, ophthalmic imagers have come from a variety of backgrounds, finding...Amnion-assisted conjunctival epithelial redirection (ACER): Enhancing stem cell transplantation treatment of total limbal stem cell deficiency
An exploration of Professor Harminder Dua’s recent work using a technique called amnion-assisted conjunctival epithelial redirection (ACER) to aid the success of conjunctival-limbal grafting procedures. ACER provides a refined way to use amniotic membrane (amnion), such as Omnigen® (NuVision® Biotherapies,...The results of the last survey Aug 2019
Thank you once again for participating in the survey. Some fascinating results once again. Almost one in five of us do not cancel cataract surgery on the day if the blood pressure (BP) is high, which I am surprised about....A refractive surprise after vitrectomy and capsulectomy
1 February 2016
| Juliana Albano de Guimaraes, Sana Rasool, John R Murdoch
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oncology, EYE - Oculoplastic, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Figure 1: Right posterior capsule small aperture. We report a case of a pseudophakic patient who underwent vitrectomy and posterior capsulectomy. In spite of good visual acuity and absence of floaters, he was unhappy with the visual outcome. Case report...
Clipboard history
5 February 2020
| David Haider
If you regularly use the clipboard on a PC or Mac to copy and paste information, you will likely appreciate how useful the feature is. Despite its utility, it fails when you copy data over something else you have yet...
My ophthalmology taster week experience at Whipps Cross Eye Treatment Centre
3 April 2023
| Phong Phan
|
EYE - General
Deciding to explore ophthalmology Having read about ophthalmology, I have always found myself fascinated about what a career in ophthalmology entails. I have often wondered what ophthalmologists actually do, as we as medical students did not have a lot of...
Study flags evidence gaps in AI eye imaging devices approved for patient care
Uneven evidence and poor data transparency revealed in review of AI as a medical device. A review of regulator-approved medical AI models in eye care has found that they vary widely in providing evidence for clinical performance and lacked transparency...In conversation with Clare Abbott (ECLO)
3 October 2022
| Rosalyn Painter, Clare Abbott
|
EYE - General
Rosalyn Painter spoke to Clare Abbott, a member of the Eye Clinic Liaison Officer (ECLO) team at Oxford Eye Hospital, about her day-to-day job as an ECLO, how the role can help patients, and the ongoing importance of their work....
Efficacy and safety of intravitreal faricimab in nAMD, DME and RVO
30 January 2025
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This paper is an analysis of data extracted from 13 eligible studies in the context of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), collected from systematic literature search of MEDLINE, Embase, and Cochrane...
Patients blinded by stem cells! How safe are they really?
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Patients blinded by stem cells! How safe are they really? Ever since the successful results following...Viva Las Vegas: Dr Corey Hochman
3 August 2023
| Peter Cackett
|
EYE - General
Speaking with Phoenix-based ophthalmologist and poker player, Dr Corey Hochman, Peter Cackett explores the themes of success and failure, and how the ups and downs of one’s ambition can provide an overwhelming gratitude for life. “Money won is twice as...
Effect of syringe-filling technique and risk for endophthalmitis after intravitreal injection of anti-VEGF agents
2 August 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Aflibercept, Anti-vascular endothelial growth factor, Bevacizumab, Endophthalmitis, Filling, Prefilled syringe, Ranibizumab, Syringe
In this retrospective study the authors compare the risk for post-injection endophthalmitis between different anti-vascular endothelial growth factor (VEGF) agents and syringe preparation technique. This multicentre study included 197,402 injections. The drugs included in this study were three Anti-VEGF agents...
